Delivery Order SPE2DB20D2014-SPE2DB25FB56A

Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,817.35, is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract is a firm-fixed price delivery order with an ultimate completion date of April 1, 2025. This contract is not designated as a set-aside and was awarded as part of Amerisourcebergen's...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AVEED 750 MG/3 ML VIAL 3ML. The firm-fixed-price contract has a ceiling value of $27,954.72 and a completion date of October 18, 2024. It is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025,...
This federal contract award, valued at $34,684.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medical product, with a period of performance through March 25, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AVEED 750 MG/3 ML vials, a specialty pharmaceutical product. The award has a ceiling value of $7,765.20 and a period of performance through November 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,684.92, is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a prescription pharmaceutical product, with a ceiling value of $7,402.50 and a completion date of September 18, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $18,636.48, is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a prescription medication. This is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract has a ceiling value of $6,988.68 and a period of performance through August 16, 2024. The contract is a firm fixed-price type and does not utilize a set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these pharmaceutical...
This federal contract award, valued at $7,765.20, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. It is a firm-fixed-price delivery order contract with a performance period ending on November 7, 2024. The contract was awarded on October 17, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $35,465.50 Firm Fixed Price Delivery Order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary vehicle for...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB56A
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a medical product, with an ultimate completion date of April 28, 2025 and a ceiling value of $9,634.70. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award was not designated with a set-aside requirement, indicating open competition.

Generated 7/7/25, 1:24 PM